Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1 alpha
4.2 Hepatotoxicity, nephrotoxicity, and cardiovascular concerns Hepatotoxicity, nephrotoxicity and cardiovascular issues are the key safety concerns related to natural supplements use in breast cancer patients especially when combined with conventional chemotherapy, targeted drugs, or supportive agents (211)
[10] [9] A skeptical reading is available and should be stated: an intervention whose reported benefits appear late, persist for a day, and continue after discontinuation is an intervention whose reported benefits are difficult to distinguish from expectation, regression to the mean, and the substantial placebo response that characterizes insomnia research generally
GLP-1 RAs are generally prescribed at higher doses for weight loss rather than for control of T2D, do GLP1-RA therapy in patients with T2D have the same incidence of gallbladder or biliary diseases compared with GLP1-RA in patients treated for obesity
